文献速递肝病

非酒精性脂肪性肝病的肝外疾病负担与死亡率:一项Meta分析的伞状综述

Extrahepatic morbidities and mortality of NAFLD: an umbrella review of meta-analyses.
PubMed 文献 · Aliment Pharmacol Ther · 2022-08-21

该伞状综述纳入22项Meta分析(含374项原始研究),检索PubMed、Web of Science和Cochrane数据库至2021年11月27日。结果显示NAFLD患者死亡、心血管并发症、肝外癌症、糖尿病和慢性肾脏病风险升高,但证据确定性仅极低至中等,需低偏倚风险研究进一步验证。

要点

  • NAFLD患者死亡、心血管并发症、肝外癌症、糖尿病和慢性肾脏病风险较无NAFLD者升高。
  • 甲状腺功能减退、尿路结石、胃食管反流病、胆结石、抑郁及不良母婴结局风险亦升高。
  • 前列腺癌、女性生殖器官癌、血液系统癌症、糖尿病视网膜病变和骨质疏松性骨折关联不显著。

核心结论

  • NAFLD患者肝外结局风险升高,但证据确定性仅极低至中等,需低偏倚风险研究支持并阐明因果关联。

研究设计与样本

  • 伞状综述,检索PubMed、Web of Science和Cochrane数据库自建库至2021年11月27日,纳入22项Meta分析(含374项原始研究)。

主要发现

  • NAFLD患者较无NAFLD者死亡、多种心血管并发症、肝外癌症、糖尿病和慢性肾脏病风险升高。
  • NAFLD患者甲状腺功能减退、尿路结石、胃食管反流病、胆结石、抑郁及不良母婴结局风险亦升高。
  • 前列腺癌、女性生殖器官癌、血液系统癌症、糖尿病视网膜病变和骨质疏松性骨折的关联不显著。
  • 肥胖与非肥胖NAFLD患者的心血管疾病、糖尿病和慢性肾脏病风险相似。
  • 多数关联存在区域异质性,欧洲NAFLD患者较北美NAFLD患者更易发生全因死亡。

关键数值与推荐

  • 证据确定性分级为极低至中等,因所有纳入研究均为观察性研究。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 所有纳入研究均为观察性研究,证据确定性仅极低至中等。
  • 多数关联存在区域异质性。
  • 需低偏倚风险研究进一步支持证据并阐明因果关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) has reached pandemic proportions currently and may contribute to multiple extrahepatic outcomes. AIM: To comprehensively summarise evidence of associations between NAFLD and risk of extrahepatic outcomes. METHODS: We conducted an umbrella review. We searched PubMed, Web of Science and Cochrane database from inception to 27 November 2021. RESULTS: We included 22 meta-analyses with 374 original studies in our analysis. Subjects with NAFLD had an increased risk of mortality, multiple cardiovascular complications, extrahepatic cancers, diabetes and chronic kidney disease (CKD) than those without NAFLD. Excess risks of several other extrahepatic outcomes including hypothyroidism, urolithiasis, gastro-oesophageal reflux disease, gallstones, depression and worse maternal and foetal outcomes were also observed in this population. However, associations were not significant for prostate cancer, female organ genital cancer, haematological cancer, diabetic retinopathy or osteoporotic fracture. The risks of CVD, diabetes and CKD were similar in obese and non-obese patients. Most associations were heterogeneous across regions; significantly, Europeans with NAFLD were more prone to all-cause mortality than North Americans. The certainty of evidence was graded from only very low to moderate as all included studies were observational. CONCLUSIONS: Patients with NAFLD are at heightened risk of extrahepatic outcomes. However, the certainty of evidence is only from very low to moderate. Further studies at low risk of bias are required to support the evidence and elucidate any causal associations.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Yi M, Peng W, Feng X, et al. Extrahepatic morbidities and mortality of NAFLD: an umbrella review of meta-analyses. Aliment Pharmacol Ther. 2022. PMID: 35989292. doi:10.1111/apt.17165

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。